|
|
BrpuzdYTacXNfNV |
|
392 |
|
|
Best Site good looking https://fixtron24.com/stmap_64hv3x6.html flagyl price uk Bristol-Myers Squibb cancer drug Yervoy failed to show a statistically significant impact on overall survival in patients with prostate cancer who have previously received chemo. The company said in its Phase III clinical trial announcement Thursday that although the drug failed to meet its primary goal, it did show some benefits, and that the data indicated âgreater activityâ in patients whose castration-resistant prostate cancer was less advanced. |
|
|
Sonny |
|
2020-04-15 13:18:33 |
|
|
|
|
|
|
|
|